|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.567 SEK | +6.38% |
|
+2.53% | +24.21% |
Active Biotech AB (publ) reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net loss was SEK 58.4 million compared to SEK 49.8 million a year ago. Basic loss per share from continuing operations was SEK 0.25 compared to SEK 0.23 a year ago.
Diluted loss per share from continuing operations was SEK 0.25 compared to SEK 0.23 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +24.21% | 18.71M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.73B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
ACTIVE BIOTECH AB 
